Z-0379-2013 Class III Terminated
FDA device recall Z-0379-2013 was initiated by Microgenics Corporation on Aug 20, 2012 and is designated Class III. Reason for recall: In house testing confirmed that CK-MS and Insulin claimed in both Omni IMMUNE and Omni IMMUNE PRO products are displaying reduced stability. The recall status is terminated (terminated Mar 4, 2013). Affected quantity: 2076 total in US , 596 total Foreign.
Recall details
- Product Type
- Devices
- Report Date
- Nov 28, 2012
- Initiation Date
- Aug 20, 2012
- Termination Date
- Mar 4, 2013
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2076 total in US , 596 total Foreign
Product description
Reason for recall
Distribution pattern
Worldwide Distribution--USA (nationwide) and the countries of Germany, Canada and Australia.
Code information
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-0379-2013
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for Microgenics Corporation? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.